Fungal infection in lung transplantation

Area of Science:

• * Medical Mycology
• * Transplant Surgery
• * Immunology

Background:

• * Lung transplant recipients face a high risk of fungal infections, a significant cause of morbidity and mortality.
• * The lung allograft's direct exposure to the environment makes it susceptible to fungal spores and pathogens.
• * Pre-existing lung conditions, surgical complications, and immunosuppression regimens increase infection risk.

Purpose of the Study:

• * To review risk factors, timing, and common fungal pathogens in lung transplant recipients.
• * To discuss the importance of identifying at-risk patients for prophylaxis and preemptive strategies.
• * To explore current and future antifungal treatment options.

Main Methods:

• * Literature review of fungal infections in lung transplant recipients.
• * Analysis of risk factors, temporal patterns, and causative fungal agents.
• * Discussion of clinical management strategies and research directions.

Main Results:

• * Fungal infections are a significant threat post-lung transplant, influenced by various factors.
• * Infections manifest differently over time: early (surgical), 1-6 months (opportunistic/relapsed), and >6 months (chronic rejection related).
• * Aspergillus species are the most common, followed by Candida, Pneumocystis, and Cryptococcus.

Conclusions:

• * Proactive identification and management of at-risk lung transplant recipients are crucial for preventing fungal infections.
• * Tailored antifungal prophylaxis and preemptive strategies are essential.
• * Ongoing research into novel antifungal agents and treatment protocols is necessary.